Isolation of biologically-active exosomes from human plasma.

[1]  R. Schiffelers,et al.  Toward routine detection of extracellular vesicles in clinical samples , 2014, International journal of laboratory hematology.

[2]  A. Falus,et al.  Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube. , 2014, Thrombosis research.

[3]  X. Breakefield,et al.  Heparin blocks transfer of extracellular vesicles between donor and recipient cells , 2013, Journal of Neuro-Oncology.

[4]  T. Whiteside,et al.  Adenosine production by human B cells and B cell-mediated suppression of activated T cells. , 2013, Blood.

[5]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[6]  T. Whiteside.  Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). , 2013, Biochemical Society transactions.

[7]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[8]  A. Morelli,et al.  Methods of analysis of dendritic cell-derived exosome-shuttle microRNA and its horizontal propagation between dendritic cells. , 2013, Methods in molecular biology.

[9]  N. Huh,et al.  A direct extraction method for microRNAs from exosomes captured by immunoaffinity beads. , 2012, Analytical biochemistry.

[10]  N. Huh,et al.  Noble polymeric surface conjugated with zwitterionic moieties and antibodies for the isolation of exosomes from human serum. , 2012, Bioconjugate chemistry.

[11]  R. Setterquist,et al.  Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. , 2012, Biochimica et biophysica acta.

[12]  Graham M Lord,et al.  A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. , 2012, Blood.

[13]  V. Miller,et al.  Methodology for isolation, identification and characterization of microvesicles in peripheral blood. , 2012, Journal of immunological methods.

[14]  D. Webb,et al.  Identification and proteomic profiling of exosomes in human cerebrospinal fluid , 2012, Journal of Translational Medicine.

[15]  Bernd Giebel,et al.  Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. , 2011, Colloids and surfaces. B, Biointerfaces.

[16]  A. Putnam,et al.  Rapid assessment of in vitro expanded human regulatory T cell function. , 2011, Journal of immunological methods.

[17]  S. Mathivanan,et al.  ExoCarta: A compendium of exosomal proteins and RNA , 2009, Proteomics.

[18]  Richard J. Simpson,et al.  Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein Signature* , 2009, Molecular & Cellular Proteomics.

[19]  Carmen Visus,et al.  Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes1 , 2009, The Journal of Immunology.

[20]  J. Rush,et al.  The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid , 2009, Cerebrospinal Fluid Research.

[21]  D. Bigner,et al.  Proteomic and immunologic analyses of brain tumor exosomes , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[23]  G. Kristiansen,et al.  Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. , 2007, Gynecologic oncology.

[24]  P. Altevogt,et al.  CD24 is a marker of exosomes secreted into urine and amniotic fluid. , 2007, Kidney international.

[25]  P. Robbins,et al.  Modulation of the immune response using dendritic cell-derived exosomes. , 2007, Methods in molecular biology.

[26]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[27]  Simon C Watkins,et al.  Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  Rong-Fong Shen,et al.  Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Kaler,et al.  Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Whiteside,et al.  T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[32]  Douglas D. Taylor,et al.  Shed membrane fragment-associated markers for endometrial and ovarian cancers. , 2002, Gynecologic oncology.

[33]  Douglas D. Taylor,et al.  Shed Membrane Fragment-Associated Markers for Endometrial and Ovarian Cancers , 2002 .

[34]  M. Mason,et al.  Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. , 2001, Journal of immunological methods.

[35]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.